{
    "2021-07-08": [
        [
            {
                "time": "",
                "original_text": "对比片仔癀，云南白药掉队了吗？",
                "features": {
                    "keywords": [
                        "片仔癀",
                        "云南白药",
                        "对比",
                        "掉队"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "中银基金管理有限公司旗下12只基金披露最新一期季报",
                "features": {
                    "keywords": [
                        "中银基金",
                        "季报",
                        "基金"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中银基金旗下部分产品二季报出炉，个别债基标的受监管处罚，刘潇大幅加仓云南白药、丽珠集团、大参林",
                "features": {
                    "keywords": [
                        "中银基金",
                        "二季报",
                        "监管处罚",
                        "云南白药",
                        "丽珠集团",
                        "大参林",
                        "加仓"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "仁和药业以7.19亿拿下多家企业",
                "features": {
                    "keywords": [
                        "仁和药业",
                        "收购",
                        "企业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "确认！华润医药收购博雅生物",
                "features": {
                    "keywords": [
                        "华润医药",
                        "博雅生物",
                        "收购"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药：未来十年，由创新驱动迈入全球制药20强",
                "features": {
                    "keywords": [
                        "上海医药",
                        "创新",
                        "全球制药20强",
                        "未来十年"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}